viral replication inhibitors (Haplogen/Bayer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameviral replication inhibitors (Haplogen/Bayer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveRespirovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustriaGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHaplogen Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHaplogen GmbhBayer AG
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveRespirovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A